Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (AJMC®). She joined AJMC® in 2013 and is the primary staff editor for Evidence-Based Oncology, the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for AJMC®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for AJMC readers.
Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on LinkedIn.
Measuring Cortisol Levels in Hair Shows Link Between Stress, Obesity
For some time, studies have shown a link between elevated stress and obesity. Measuring cortisol levels in the hair may be a better way to evaluate chronic stress, since the hormone level will not fluctuate from day to day.
TAPUR Trial Expands Who Can Join Clinical Trials, If Payers Fund Genomic Tests
Pam Mangat, MS, associate director for the TAPUR study in the research and analysis division of the American Society of Clinical Oncology, offered an update on the study at the 5th annual Patient-Centered Oncology Care® meeting.
Comparing Surgery, Medication for Type 2 Diabetes in Overweight Patients
This small study found sustained weight loss of 10% of body weight in patients who were overweight but not obese, along with improvements in glycemic control and quality of life that exceeded patients taking medication only.
House GOP Replacement for Obamacare Takes Shape
The policy brief outlines House GOP thinking on a universal, refundable, and portable tax credit, state-based high-risk pools, and how to repeal Medicaid expansion. But many specifics, including what it would cost a typical family, are unclear.
Christie Signs Nation's Strictest Opioid Treatment Mandate, Prescription Limit
Moments after the bill cleared the General Assembly, NJ Governor Chris Christie signed into law requirements that insurers pay for 6 months of treatment, limit the first opioid script to 5 days, and educate prescribers on the dangers of addiction.
New Jersey Poised to Pass Opioid Treatment Mandate - and Health Plans Are Part of the Solution
The legislature is expected to give final passage to the nation's strictest treatment mandates and a 5-day cap on the initial opioid prescription. Governor Chris Christie's plan has met little resistance, even though the cost is unknown.
PhRMA Takes Aim at IPAB, a Longtime Target
Lawmakers from both parties have expressed their dislike for an entity that could take away their spending authority. But a leading Democrat also raised the fact that the new HHS Secretary, Tom Price, MD, would be harsh on the most vulnerable.